Company intelligence / Profile preview

Gasporox

Ownership: Private
Employees: ~10
Development stage: Commercial

Overview

Gasporox has commercialized a suite of laser-based instruments and sensor modules that enable non-destructive, non-intrusive headspace gas analysis and leak detection in pharmaceutical, food, and beverage packaging. Their technology meets regulatory standards such as USP1207 and EU GMP Annex 1. The company won the CPHI Pharma Award in 2023 for Packaging & Machinery innovation.

No clinical results are relevant as the company does not develop therapeutics.

Modalities: Device (laser-based sensors and instruments for headspace gas analysis and leak detection)
Industry: Drug Discovery Services

Partnerships

No major pharma/biotech partnerships specifically listed; collaborates with machine builders, end-users/laboratories globally.

Beyond the preview

Go deeper on Gasporox.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gasporox.

Explore the full profile